Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshmi A Devi

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
The Mount Sinai Journal of Medicine, New York|August 1, 2006
The use of receptor-specific antibodies to study G-protein-coupled receptorsAchla Gupta, Lakshmi A Devi
Progress in Molecular Biology and Translational Science|August 10, 2010
Escorts take the lead molecular chaperones as therapeutic targetsDumaine Williams, Lakshmi A Devi
Nature|May 19, 2012
Structural biology: How opioid drugs bind to receptorsMarta Filizola, Lakshmi A Devi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 13, 2008
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3Raphael Rozenfeld, Lakshmi A Devi
Nature|February 21, 2020
Strategy for making safer opioids bolsteredSusruta Majumdar, Lakshmi A Devi
The Biochemical Journal|December 17, 2010
Exploring a role for heteromerization in GPCR signalling specificityRaphael Rozenfeld, Lakshmi A Devi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimersRaphael Rozenfeld, Lakshmi A Devi
Trends in Pharmacological Sciences|January 12, 2010
Receptor heteromerization and drug discoveryRaphael Rozenfeld, Lakshmi A Devi
Nature|January 19, 2018
Strategy for making safer opioids bolsteredSusruta Majumdar, Lakshmi A Devi
Trends in Pharmacological Sciences|November 7, 2012
Grand opening of structure-guided design for novel opioidsMarta Filizola, Lakshmi A Devi
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
The Mount Sinai Journal of Medicine, New York|August 1, 2006
The use of receptor-specific antibodies to study G-protein-coupled receptorsAchla Gupta, Lakshmi A Devi
Progress in Molecular Biology and Translational Science|August 10, 2010
Escorts take the lead molecular chaperones as therapeutic targetsDumaine Williams, Lakshmi A Devi
Nature|May 19, 2012
Structural biology: How opioid drugs bind to receptorsMarta Filizola, Lakshmi A Devi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 13, 2008
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3Raphael Rozenfeld, Lakshmi A Devi
Nature|February 21, 2020
Strategy for making safer opioids bolsteredSusruta Majumdar, Lakshmi A Devi
The Biochemical Journal|December 17, 2010
Exploring a role for heteromerization in GPCR signalling specificityRaphael Rozenfeld, Lakshmi A Devi
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimersRaphael Rozenfeld, Lakshmi A Devi
Trends in Pharmacological Sciences|January 12, 2010
Receptor heteromerization and drug discoveryRaphael Rozenfeld, Lakshmi A Devi
Nature|January 19, 2018
Strategy for making safer opioids bolsteredSusruta Majumdar, Lakshmi A Devi
Trends in Pharmacological Sciences|November 7, 2012
Grand opening of structure-guided design for novel opioidsMarta Filizola, Lakshmi A Devi
Pageof 14